|
Imagine
living in a world where fluorescent lights scream like chainsaws,
sunlight pierces like a laser and visual images shatter into fragments.
More than half a million Americans live in some variation of that
red-alert, anxiety-filled world those individuals diagnosed with
autism or some form of pervasive developmental disorder (PDD) that
usually appears during the first three years of life.
Autism
is a complex developmental disability that affects normal brain
development, according to the Autism Society of America. Several
related disorders are grouped together under PDD, all characterized
by severe and pervasive impairment in social interaction and communication
skills.
The
disability, which may be mild or severe, is four times more prevalent
in boys, and about 75 percent of affected individuals test in the
range of mental retardation. Those who test above normal I.Q. are
called "high functioning" and may hold jobs.
No
cause, no cure
The
prevalence rate for autism, estimated by the CDC to affect one in
500 individuals, has escalated at an alarming rate in certain regions,
where increases of up to one in 150 individuals have been reported.
Health
experts have responded with more studies and treatments for a disorder
with no proven cause or cure, even as existing services for developmentally
disabled patients are overwhelmed. Scientists and parents are pursuing
every possible connection or treatment that could pinpoint a cause
or relieve painful symptoms for children who have become profoundly
isolated and unable to respond to others.
"We
have several medical intervention studies, one of which is a double-blind
placebo control study of children within the PDD spectrum taking
risperidone, which is approved for adults for problems such as inattention,
anxiety, obsessive-compulsive behavior or aggressive and self-injurious
behavior," said Kathy Koenig, MSN, an associate research scientist
at Yale Child Study Center in New Haven, Conn.
"We
also have social skills intervention studies because early training
can help these children, and one new study is on explicit explanations
of eye contact skills, turn-taking in conversation and others. Any
improvement is progress."
Autism
is treated with speech/language therapy, physical therapy, sensory
integration, occupational therapy, applied behavior analysis, medications
and dietary interventions, but more research is needed to determine
the most effective treatments for each disability. Early diagnosis
and intervention are crucial.
Researching
a reason
Many
experts are looking for possible biomarkers in blood or genes that
could indicate a child’s predisposition to autism, while others
are examining levels of medications or chemicals that may be involved
in triggering the disability to cause the increase in prevalence.
"Very
often, autism develops after a series of vaccines, or maternal measles,
or a series of antibiotics for infections these things tend
to precede the diagnosis," said Sharla Perel, MS, OT, who has
worked with autistic children at P.S. 77 in Borough Park, N.Y.,
for 10 years. "There’s enough evidence for correlation that
one has to look at these things."
One
team developed the Defeat Autism Now protocol, a guide for parents
and practitioners to reduce food allergies, mineral deficiencies,
yeast overgrowth and medication toxicities that, when eliminated,
have helped autistic individuals progress, according to Maureen
McDonnell, RN, owner and director of Health Education Services in
Pennington, N.J.
Another
group has identified a preservative in some pediatric vaccines,
thimerosal, as a trigger for autism. Thimerosal contains 49.6 percent
mercury by weight and has been scientifically associated with a
number of neurological disorders including autism, attention deficit
disorder, speech delays and tics, said Lyn Redwood, MSN, FNP, president
of the Coalition for Safe Minds in Tyrone, Ga.
"We
feel strongly this epidemic has been the result of mercury exposure,"
Redwood said.
In
1998, parents and physicians launched the Medical Investigation
of Neurodevelopmental Disorders Institute in Davis because they
believed a possible link existed between environmental contributions
and neurodevelopmental disorders. The institute received $34 million
from the state of California in June to pursue 19 studies, which
now are under way.
"Estimates
from the NIH show that 17 percent to 29 percent of all American
children have neurodevelopmental disorders," said David Amaral,
Ph.D., professor at the UC Davis department of psychiatry.
"I’m
a neuroscientist, not an immunologist, and it might be environmental
exposure or some change in pediatric care policy, but we’re facing
an incredible lack of knowledge.
"It’s
a win-win to conduct the vaccine study in a neutral way. If investigations
show a clear link between vaccines and autism, then we could prevent
future cases," said Amaral, who is also the institute’s research
director. "If, conversely, we can’t demonstrate a link, that
would be reassuring to parents."
Meanwhile,
autistic children can greatly benefit from applied behavior analysis
at schools like the ABC School in Sacramento.
"We
use a set of principles to reinforce specific behaviors," said
Michelle Williams-Wenell, ABC school public relations and development
specialist. "Our data shows that 40 percent of the kids who
come here before the age of 4 years and 1 month have gone on to
full-inclusion settings."
|